Figure 2 | European Journal of Clinical Nutrition

Figure 2

From: An open-label dosing study to evaluate the safety and effects of a dietary plant-derived polysaccharide supplement on the N-glycosylation status of serum glycoproteins in healthy subjects

Figure 2

Results from the pilot study; examining possible changes in serum protein N-glycosylation in response to different doses of AA. The MS percentage intensity for G0, G1, G1F and A2, for each of the six volunteers, at four time points is shown. Week 0 (baseline), week1 (AA at 1.3 g/day), week 7 (AA at 9.1 g/day) and week 11 (n=3 continued to take increasing doses of AA, reaching a final dose of 14.3 g/day, represented by the solid line; and n=3 discontinued their AA supplementation, represented by dashed line, respectively).

Back to article page